Drug Database
Back to search

Netherlands· NL-0bb5f210ced5

Innohep 4.500 IE anti-Xa/0,45 ml, oplossing voor injectie

A tinzaparin product containing tinzaparine natrium, registered in Netherlands by LEO Pharma B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC B01AB10

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedInnohep 4.500 IE anti-Xa/0,45 ml, opl…ATCB01AB10REGISTER NO.NL-0bb5f210ced5PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tinzaparine natriumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tinzaparin is registered in 9 of 19 countries.

Countries holding a registration under ATC B01AB10 (tinzaparin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose
Search tinzaparin products by name

Tinzaparin · ATC B01AB10

9 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TINZAPARINE NATRIUM
Manufacturer
LEO Pharma B.V.
Country
Netherlands (NL)
ATC code
B01AB10
ATC class
Tinzaparin
Defined daily dose
3.5 TSD, E
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    22478

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

162 interactions on record for tinzaparin.

Graded by severity as the source publishes them — 94 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tinzaparin against other medicinesHow interaction checks work

Tinzaparin · interactions on record

162 records

  • 94 severe
  • 68 moderate

Most severe, free to view

  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tinzaparin in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tinzaparin products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Greece · Innohep
  • Sweden · Innohep

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b3359154-705e-4d8e-81f2-7b4184068c69
GET /v1/drugs/b3359154-705e-4d8e-81f2-7b4184068c69?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h22478_smpc.pdf",
  "strength": null,
  "atc_label": "Tinzaparin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg22478",
  "excipients": [
    "NATRIUMACETAAT 3-WATER (E 262)",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "TINZAPARINE NATRIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h22478.pdf",
  "authorised_at": "1999/07/06",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "22478",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about tinzaparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console